îæ€çŽ¢
îæ€çŽ¢
î
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
DMIIRîãŠã©ãããªã¹ãã«è¿œå
0.081USD
+0.000+0.25%
çµå€Â 07/02, 13:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
0.00æ䟡ç·é¡
--çŽè¿12ã¶æPER
詳现ãã£ãŒãã衚瀺
TradingKey åŸè¡šIntraday
1m
30m
1h
D
W
M
D
æ¬æ¥
+0.25%
5æ¥é
-7.32%
1ã¶æ
-10.10%
6ã¶æ
-42.14%
幎åæ¥
-42.14%
1幎é
0.00%
äž»èŠããŒã¿
0.081å§å€
0.100é«å€
14.09Kåºæ¥é«
--çŽè¿12ã¶æPER
--äºæ³PER
--çŽè¿12ã¶æé
åœ
--売買å転ç
0.081åæ¥çµå€
0.081å®å€
1.18K売買代é
--æ ªäŸ¡åçç
--PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
--ç·è³ç£å©çç
0.17052é±é«å€
0.89åºæ¥é«æ¯ç%
--çŽå©ç
--æ ªåŒæ°
--1æ ªåœããå©çïŒEPSïŒ
--ããŒã¿å€
--èªå·±è³æ¬å©çç
0.06052é±å®å€
23.76%æ¯ãå¹
--ç²å©çç
0.00æ䟡ç·é¡
0.12ãªã¹ã¯ãªã¿ãŒã³
8.07%ãªã¹ã¯ç
TradingKey æ ªåŒã¹ã³ã¢
ããŒã¿ãäžååãªãããæ ªåŒã¹ã³ã¢ã¯å©çšã§ããŸããã
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
財åææšî
EPS
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®äŒæ¥æ å ±î
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
äŒæ¥ã³ãŒãDMIIR
äŒæ¥åDrugs Made In America Acquisition II Rights Exp 16 Sep 2030
æé«çµå¶è²¬ä»»è
ãCEOãStockwell (Lynn)
ãŠã§ããµã€ã
人æ°éæ
52852.900
+10.400Â (+0.02%)
29669.900
+358.500Â (+1.22%)
7507.800
+36.300Â (+0.49%)
14963.000
+160.000Â (+1.08%)
69676.000
+1528.000Â (+2.24%)
6412.400
+59.600Â (+0.94%)
68.683
+0.339Â (+0.50%)
308.630
+14.250Â (+4.84%)
194.830
-2.750Â (-1.39%)
4174.610
+52.700Â (+1.28%)
ãããã質å
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030ïŒDMIIRïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îDrugs Made In America Acquisition II Rights Exp 16 Sep 2030ïŒDMIIRïŒã®çŸåšã®æ ªäŸ¡ã¯0.08ã§ãã
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îDrugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®ãã£ãã«ãŒã·ã³ãã«ã¯DMIIRã§ãã
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®52é±é«å€ã¯ãããã§ããïŒ
îDrugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®52é±é«å€ã¯0.17ã§ãã
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®52é±å®å€ã¯ãããã§ããïŒ
îDrugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®52é±å®å€ã¯0.06ã§ãã
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®æ䟡ç·é¡ã¯ãããã§ããïŒ
îDrugs Made In America Acquisition II Rights Exp 16 Sep 2030ã®æ䟡ç·é¡ã¯642.73Mã§ãã